Zimmer Biomet (ZBH) PT Raised to $138 at Baird on 4Q Report; 'Revenues Shows Signs of Stabilization'
Tweet Send to a Friend
Baird raised its price target on Zimmer Biomet (NYSE: ZBH) to $138.00 (from $130.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
